Climbing New Mountains: How Antibodies Blocking α4β7 Integrins Tamed Eosinophilic Inflammation of the Intestinal Tract

Dig Dis Sci. 2019 Aug;64(8):2068-2071. doi: 10.1007/s10620-019-05706-3.

Courtney L Olbrich^{1

2}, Luke Simerly^{1

2}, Edwin F de Zoeten^{1

2

3}, Glenn T Furuta^{1

2

3}, Lisa A Spencer^{4

5

6}

¹ Department of Pediatrics, Gastrointestinal Eosinophilic Diseases Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, 12700 East 19th Avenue, Research 2 P15-6026 Mail Stop: C-226, Aurora, CO, 80045, USA.
² Digestive Health Institute, Children's Hospital Colorado, Aurora, CO, USA.
³ Department of Medicine, Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, CO, 80045, USA.
⁴ Department of Pediatrics, Gastrointestinal Eosinophilic Diseases Program, Section of Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, 12700 East 19th Avenue, Research 2 P15-6026 Mail Stop: C-226, Aurora, CO, 80045, USA. Lisa.Spencer@ucdenver.edu.
⁵ Digestive Health Institute, Children's Hospital Colorado, Aurora, CO, USA. Lisa.Spencer@ucdenver.edu.
⁶ Department of Medicine, Mucosal Inflammation Program, University of Colorado School of Medicine, Aurora, CO, 80045, USA. Lisa.Spencer@ucdenver.edu.

No abstract available

Publication types